Pharmacogenomic considerations in drug delivery

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.4, Iss.4, 2003-07, pp. : 443-461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenomic considerations for immunosuppressive therapy

By Yagil Yoram Yagil Chana

Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. : 309-319

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomic considerations of the paraoxonase polymorphisms

By Furlong Clement E Cole Toby B Jarvik Gail P Costa Lucio G

Pharmacogenomics, Vol. 3, Iss. 3, 2002-05 ,pp. : 341-348

Future Medicine

Access to resources Recommend Favorite

Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations

By Wijagkanalan Wassana Kawakami Shigeru Hashida Mitsuru

Pharmaceutical Research, Vol. 28, Iss. 7, 2011-07 ,pp. : 1500-1519

Springer Publishing Company

Access to resources Recommend Favorite

Intravesical Drug Delivery: Pharmacokinetic and Clinical Considerations

By Highley M.S.

Clinical Pharmacokinetics, Vol. 37, Iss. 1, 1999-07 ,pp. : 59-73

Adis International

Access to resources Recommend Favorite

Clinical Considerations of Focal Drug Delivery in Cancer Treatment

Current Drug Delivery, Vol. 14, Iss. 5, 2017-07 ,pp. : 588-596

Bentham Science Publishers

Access to resources Recommend Favorite